Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
A woman wearing a yellow shirt smiles as she checks her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bell Potter has initiated coverage on Orica with a buy rating and a $23.00 price target, citing its transformation and expected growth in underlying EBIT, along with potential for increased shareholder returns through share buy-backs and dividends
  • Citi has upgraded Pro Medicus to a buy rating with a $350.00 target, highlighting its strong earnings growth outlook supported by long-term contracts, high renewal rates, and the potential growth facilitated by artificial intelligence.
  • UBS has maintained its buy rating on Zip Co with a price target of $5.25, driven by strong app download data in July and August indicating continued momentum and a positive outlook for FY 2026.

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Orica Ltd (ASX: ORI)

According to a note out of Bell Potter, its analysts have initiated coverage on this commercial explosives company's shares with a buy rating and $23.00 price target. The broker is feeling positive about Orica's outlook following its transformation in recent years. In fact, it expects the company to grow underlying EBIT across each segment in the short-to-medium term. Bell Potter also believes that the company is well positioned to deliver rapid de-leveraging over FY 2026 to FY 2027 (in the absence of M&A). It expects this to allow Orica's board to prioritise increasing shareholder returns via an extension to the share buy-back program and dividends. The Orica share price is trading at $21.23 on Friday.

Pro Medicus Ltd (ASX: PME)

A note out of Citi reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with a significantly improved price target of $350.00. Although Citi concedes that Pro Medicus shares trade on high multiples, it believes this is justified due to its strong earnings growth outlook. It notes that this is being underpinned by its sticky product offering, long contracts, high renewal rates, and an industry challenged by radiologist constraints. The broker has boosted its revenue growth estimates. It also highlights its belief that artificial intelligence will be supportive of Pro Medicus' growth and margin expansion in the medium term. The Pro Medicus share price is fetching $317.63 at the time of writing.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later (BNPL) provider's shares with an improved price target of $5.25. According to the note, the broker is feeling even more bullish on Zip's outlook after reviewing app store data. It highlights that the data indicates that downloads increased strongly in July and August, which bodes well for its performance in FY 2026 and indicates that its strong momentum is continuing. Especially given how resilient US retail sales have been. In light of this, it has boosted its earnings estimates for the medium term and its valuation to reflect this. The Zip share price is trading at $4.71 this afternoon.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A colourfully dressed young skydiver wearing heavy gold gloves smiles and gives a thumbs up as he falls through the sky.
Broker Notes

Bell Potter says this ASX silver stock has 'a sky full of upside'

This exciting stock could be a high risk, high reward pick according to the broker.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Broker Notes

These 2 ASX All Ords shares tripled in value last year. Can they keep going?

Both of these ASX shares more than tripled their market capitalisations in 2025.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »